Avantax Advisory Services’s Rockwell Medical RMTI Stock Holding History

Avantax Advisory Services’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-191	Closed	-$10K	–	1377
2022 Q1	$10K	Buy	+191	New	+$8.09K	﹤0.01%	1275
2020 Q4	–	Sell	-99	Closed	-$12K	–	1274
2020 Q3	$12K	Buy	+99	New	+$17.1K	﹤0.01%	1365

Other funds holding RMTI

Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SkyOak Wealth Southfield, Michigan $546M AUM 18.14% 1-Year Est. Return

Avantax Advisory Services's RMTI Position: Q2 2022 in Review

Avantax Advisory Services sold out of Rockwell Medical (RMTI) in Q2 2022, closing a stake of 191 shares — an estimated $10K sold.

Avantax Advisory Services first reported a position in RMTI in Q3 2020 and held it in 2 quarters. The position peaked at $12K in Q3 2020. 36 funds tracked by Wall St. Rank hold RMTI as of Q2 2022.

Avantax Advisory Services reported no remaining Rockwell Medical position as of Q2 2022 after selling out during the quarter.
Avantax Advisory Services sold 191 Rockwell Medical shares in Q2 2022, an estimated $10K.
Avantax Advisory Services first reported a position in Rockwell Medical in Q3 2020 and held it in 2 quarters.
Avantax Advisory Services's Rockwell Medical position peaked at $12K in Q3 2020.
36 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2022.

Based on Avantax Advisory Services's 13F filing for Q2 2022, filed 2 Aug 2022.